Evidently, the claim that HLA-Ib is upregulated concomitantly with the downregulation of HLA-Ia should be modified as HLA-Ia Face-2, and possibly Face-3 and Face-4 variants are upregulated concomitantly with the downregulation of HLA-Ia Face-1 on cancer cells. This evidence concerns the gene ZMPSTE24 and cancer.